Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

114.59
Delayed Data
As of Feb 22
 -2.51 / -2.14%
Today’s Change
96.18
Today|||52-Week Range
149.34
-4.18%
Year-to-Date

Today’s Trading

Previous close117.10
Today’s open117.74
Day’s range114.09 - 118.26
Volume1,812,338
Average volume (3 months)2,205,421
Market cap$26.0B
Data as of 4:00pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)+11.93%
Earnings growth (this year)+16.25%
Earnings growth (next 5 years)+18.53%
Revenue growth (last year)+17.32%
P/E ratio58.2
Price/Sales7.63
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.26+0.32%
BAXBaxter International...+0.38+0.57%
INCYIncyte Corp+0.48+0.57%
VRTXVertex Pharmaceutica...-0.30-0.19%
Data as of 4:15pm ET, 02/22/2018

Financials

Next reporting dateApril 26, 2018
EPS forecast (this quarter)$1.27
Annual revenue (last year)$3.5B
Annual profit (last year)$443.3M
Net profit margin12.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts